State health policy advocates say the drug importation measure in the Senate’s latest version of FDA user fee reauthorization legislation could hurt states’ plans to import Canadian drugs. As of July, six states had passed laws to establish drug importation programs, and they are designing programs that fit the requirements in a final Trump-era rule to allow states to import Canadian drugs. In a July 15 blog post, the National Academy for State Health Policy highlights policies in the Senate’s...